APOLLO HOSPITALS Q3 EARNINGS
Hot Stocks: Brokerage view on Stylam, Apollo Hospitals, ICICI Bank and Adani Wilmar
Investec's diversified coverage includes insights on Adani Wilmar, ICICI Bank, Apollo Hospitals, Stylam Industries, and Ratnaveer Precision Engineering, providing a comprehensive view of the market opportunities and risks.
Expect improvement in occupancy vis-a-vis the previous year from Q2: Patanjali G Keswani, Lemon Tree Hotels
While you can say that in spite of heat it was decent performance, I am looking at trend lines and I expect the catch up will happen really from Q2 when there will be improvements vis-a-vis the previous year in occupancy.
These healthcare and pharma stocks may deliver more than 20% in one year
Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components - earnings, fundamentals, relative valuation, risk and price momentum to generate standardized scores. SR+ Reports is a complimentary offering to ETPrime members.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Planning to invest Rs 3,000 crores to add 2,000 beds in 3 years: Suneeta Reddy, Apollo Hospitals
Let us look at both ARPOB, it is over 59,000, it is about Rs 59,0330. We have seen an increase in ARPOB of around 12%, but more importantly just going forward, this is because of a better case mix and price, but definitely improved case mix. With regard to volumes, inpatient volumes grew by 6%, outpatient volumes grew by 9%. And our ARPOB is net of doctors’ fees.
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
- Go To Page 1
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Apollo Hospitals Q4 results today: What to expect
Apollo Hospitals is expected to post healthy growth in core earnings for the quarter ended March 2024 due to improved ARPOB and Healthco operations. Analysts predict a 68% year-on-year growth in net profit for the fourth quarter.
Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday
Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.
GIFT Nifty down 60 points; here's the trading setup for today's session
"On the domestic front, though FII selling intensity has reduced, the caution is increasing as we near the big event outcome which is resulting in profit booking. The volatility is expected to be heightened in coming sessions, thus it's advisable to traders to stay on the sidelines and not get too aggressive. The weak global cues are further adding to the nervousness and thus markets are likely to remain weak in near future," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
EIH Limited Q4 Results: PAT jumps 169% YoY to Rs 247.6 crore
EIH Limited, the flagship company of The Oberoi Group has posted a profit of Rs 677.7 crore for financial year 2024, up 105.9% year on year. The luxury hotel chain posted revenues of Rs 2626 crore for fiscal year 2024, up 25.3% year on year.
Stocks to buy: Bet on stocks with good entry points now; 5 stocks with up to 27% upside potential
Stocks to buy: Identifying recently corrected stocks with good fundamentals can be effective in the current market. Moving averages help distinguish between stocks in correction and those in a bear trend. Stocks that have seen a recent correction and are fundamentally sound can prove good investment bets.
Wipro promotes veterans; Paytm & Nykaa Q4 financials
Happy Thursday! Wipro CEO Srinivas Pallia is betting on internal talent to propel growth. This and more in today’s ETtech Morning Dispatch.
Paytm Q4 losses tripled; Oyo IPO withdrawn
Troubled fintech Paytm reported its first quarterly earnings after the RBI banned its payments bank in January. This and more in today’s ETtech Top 5.
Defensive stocks: FMCG is “passe”; 8 stocks from two sectors may be called “new defensives” with upside potential of up to 32%
1994 to 2024 is a difference of 30 years, but there is one thing which has remained constant, advice to move to defensive stocks when markets are volatile or there is an event risk. Four questions need to be asked; first, what is a defensive stock? Second, is a stock which was considered a defensive in 1994 when the Indian economy was just opening, still a defensive stock in 2024 ? Third, should there be a new definition of defensive stock in 2024 ? Last but not the least, what are the new defensive sectors or stocks?
Medanta Q4 Results: Net profit jumps 26% YoY to Rs 127.3 crore
Global Health (Medanta) reported 26% year-on-year (YoY) jump in net profit to Rs 127.3 crore in Q4FY24 due to increase in revenue growth from matured and new hospitals, along with higher patient volumes.
MakeMyTrip Q4 Results: Company posts profit of $ 171.9 million up from $ 5.4 million a year ago
MakeMyTrip reported a revenue of $ 782.5 million for financial 2024, up from $ 593 million in fiscal year 2023. The company posted a revenue of $ 202.9 million in the fourth quarter of financial year 2024, up from $ 148.5 million in quarter four of financial year 2023.
PE fund Apax to step up India play with new team
The Apax strategy is more pivoted toward control deals, given its focus on being able to have a seat on the table to drive changes. It is, however, open to partnering with quality founders and management teams in minority settings "where there's a meeting of minds," Haldea said.
Sensex can zoom to 1.5 lakh by 2029 but don't be a speculator
While there are several reasons for this surge, peaks and troughs, booms and busts are an integral part of the stock market saga - much like the waves of the sea, which incessantly rise and fall. Hence, there could be an element of “irrational exuberance”, “froth” and “bubble”.
Q4 results today: Tata Motors, Cipla among 87 companies to announce earnings
Q4 results today: Several other companies scheduled to release their financial results include Cholamandalam Finance, Eicher Motors, Finolex Industries, Jupiter LifeLine Hospitals, Kalyan Jewellers, Piramal Pharma, Punjab and Sind Bank, Spencers Retail, TCI Express, Thermax, and more.
Q4 earnings preview: Auto sector revenue to grow 15% YoY on steady PV, 2W demand
Q4 auto sector is poised for revenue growth of 15% with EBITDA expected to rise by 28%. Brokerages foresee flat margins for some OEMs. Positive 2W demand trends noted. Top picks include TVS and Tata Motors.
Narayana Health Q3 Results: Net profit jumps 22% YoY to Rs 188 crore
The average revenue per occupied bed (ARPOB) was Rs 1.41 crore in Q3FY 24 as against Rs 1.3 crore in Q3FY23. The average length of stay (ALOS) stood at 4.4 days in Q3. The outpatient volumes rose 4% YoY to 6.04 lakh, while inpatient volumes were the same at 57,000.
Q3 Results Today: Divi’s Lab, ONGC, MCX among 170 companies to announce earnings
Among other important results will be those by Aurobindo Pharma, Chemcon Speciality Chemicals, Sai Silks (Kalamandir), Mawana Sugars, MM Forgings and Yatharth Hospital & Trauma Care Services.
Apollo Hospitals Q3 Results: Net profit rises 60% YoY to Rs 245 crore
Apollo Hospitals on Thursday reported a 60% year-on-year (YoY) jump in net profit to Rs 245 crore in Q3FY24, led by growth across hospital, diagnostics, speciality and pharmacies businesses.
Apollo Hospitals Q3 Results: Cons PAT soars 59% YoY to Rs 245 crore; dividend declared at Rs 6/share
Apollo Hospitals' revenue from operations grew 14% YoY to Rs 4,851 crore, and topped the estimated Rs 4,771 crore. The healthcare services business saw a healthy 13% YoY growth in revenue during the quarter to Rs 2,483 crore, followed by the pharmacy distribution business housed under Apollo Pharmacy, which registered 17% growth in revenue to Rs 2,049 crore.
Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growth
Mankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic revenue was led by robust growth in the chronic portfolio, recovery in anti-infectives and strong growth in modern trade and hospital sales.
Q3 Results Today: Yes Bank, Macrotech Developers among 31 companies to announce earnings
JSW Steel on Thursday reported robust growth in the consolidated net profit for the quarter ended December, as the bottom line rose nearly 5 times from the year-ago period to Rs 2,415 crore and also beat ETNow estimates of Rs 1,719 crore.
Apollo Hospitals to invest Rs 3435 crore on capacity expansion, posts Rs 233 cr net profit in Q2
As part of the expansion plan, the company announced a 250-bed new hospital in Pune expandable to 425 beds in 2 years at an overall cost of Rs 675 crores. The hospital is expected to be commissioned by Q1 FY25. With this expansion, Apollo will have over 1000 beds in Maharashtra including Mumbai, Pune and Nashik.
Load More
